Sandra Mancilla Zamora Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups. Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Sandra Mancilla Zamora LinkedIn Twitter Orcid Email Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.
Degrees: Stable animal experimentation course. ABC function in 2020 Senior Clinical Analysis Technician in 2005 Higher Techniques in Pathological Anatomy and Cytology in 2001. Currently Vall d'Hebron University Hospital. VHIR-CIBBIM. FVPR since 01/11/2017 Technician in charge of the histology section of FVPR and the DDT group of the VHIR. With knowledge in environment and quality management at ISO 9001. Application management, internal positions… They also carry out research with various projects where I am in charge of the processing of the samples, making blocks, cuts, stains, immune. I give assistance the in vitro section (cell culture) and molecular biology techniques (western blot, enzymatic activities ...) and the in vivo section helping to prepare treatments, subcutaneous, intravenous cell inoculation, mammary, control of mice’s evolution, weight, tumor size, etc., necropsies and collection of biological samples for further processing. Responsible for the control of own equipment, maintenance, verification and calibration. Order control and organization of the general laboratory.
Projects SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.. IP: Ibane Abasolo Olaortua Collaborators: Marc Miquel Moltó Abad, Olga Sánchez- Maroto Carrizo, Julia German Cortes, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Belen Garcia Prats, Angels Alcina Mila, SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Maria Fidel Lledò, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Simon Schwartz Navarro Funding agency: EUROPEAN COMMISSION Funding: 649580 Reference: SAFE-N-MEDTECHEC_H2020-NMBP2018 Duration: 01/04/2019 - 30/09/2023 Smart-4-Fabry: Smart multifunctional GLA-nanoformulation for Fabry disease IP: - Collaborators: Ibane Abasolo Olaortua, Simon Schwartz Navarro, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua Funding agency: EUROPEAN COMMISSION Funding: 266300.8 Reference: SMART4FABRY_H2020NMBP2016 Duration: 01/01/2017 - 31/12/2020 NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy IP: Simon Schwartz Navarro Collaborators: Ibane Abasolo Olaortua, Joaquin Seras Franzoso, Tamara Del Rio Higueras, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez Funding agency: EUROPEAN COMMISSION Funding: 630633.55 Reference: NOCANTHER_H2020NMP2015 Duration: 01/04/2016 - 30/09/2021 Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3
